美国
证券交易委员会
华盛顿特区20549
表格
(标记一个)
根据1934年证券交易所法案第13或15(d)条的季度报告 |
截至2024年6月30日季度结束
或
根据1934年证券交易法第13条或第15(d)条的过渡报告 |
过渡期间从 至
委员会文件编号
（依凭章程所载的完整登记名称）
(依据所在地或其他管辖区) | 编号) |
(总办事处地址，包括邮递区号)
(
(注册人电话号码，包括区号)
根据法案第12(b)条规定注册的证券：
每种类别的名称 | 交易标的 | 每个注册交易所的名称 |
按照勾选的方式指示登记人（1）在前12个月内是否已提交证券交易法1934年第13条或第15（d）条要求提交的所有报告（或者对于登记人要求提交此类报告的更短的期间），以及（2）在过去的90天内是否一直受到此提交要求的约束。
请勾选表示，申报人根据第405条Regulation S-t规定，在过去12个月内（或者对于申报人要求提交此类档案的较短期间），是否已电子提交每一个交互式数据文件。405规则的通过，规定在先前的12个月内提交每一个互动数据文件（或者对于申报人需要提交此类文件的较短期间）。
请载明检查标记，公司是否为大型加速披露人、加速披露人、非加速披露人、小型报告公司或新兴成长公司。请于「交易所法案」第1202条中查阅「大型加速披露人」、「加速披露人」、「小型报告公司」和「新兴成长公司」的定义。
加速披露人☐ | ||
非加速提交者☐ | 较小型报告公司 | |
新兴成长公司 |
如果一家新兴成长型公司，请用核选标记表示，是否已选择不使用根据《交易法》第13(a)条提供的遵守任何新的或修改后的财务会计准则的延长过渡期。 ☐
请用核选标记表示，登记公司是否是空壳公司（根据《交易法》第120亿2条定义） 是
截至2024年11月4日，有
第一部分—财务资讯
项目1。基本报表。
Axcelis Technologies, Inc.
综合损益表
(以千为单位，每股金额除外)
(Unaudited)
截至三个月结束 | 截至九月三十日的九个月 | ||||||||||||
九月三十日， | 九月三十日， | ||||||||||||
| 2024 |
| 2023 |
| 2024 |
| 2023 |
| |||||
营业收入: | |||||||||||||
产品 | $ | | $ | | $ | | $ | | |||||
服务 |
| |
| |
| |
| | |||||
营业总收入 |
| |
| |
| |
| | |||||
营业成本: | |||||||||||||
产品 |
| |
| |
| |
| | |||||
服务 |
| |
| |
| |
| | |||||
总营业成本 |
| |
| |
| |
| | |||||
毛利润 |
| |
| |
| |
| | |||||
营业费用： | |||||||||||||
研究与发展 |
| |
| |
| |
| | |||||
销售和市场营销 |
| |
| |
| |
| | |||||
总务及行政 |
| |
| |
| |
| | |||||
总营业费用 |
| |
| |
| |
| | |||||
营业收入 |
| |
| |
| |
| | |||||
其他收入（费用）： | |||||||||||||
利息收入 |
| |
| |
| |
| | |||||
利息支出 |
| ( |
| ( |
| ( |
| ( | |||||
其他，净值 |
| |
| ( |
| |
| ( | |||||
其他收益合计 |
| |
| |
| |
| | |||||
税前收入 |
| |
| |
| |
| | |||||
所得税负担 |
| |
| |
| |
| | |||||
净收入 | $ | | $ | | $ | | $ | | |||||
每股净利润： | |||||||||||||
基本 | $ | $ | $ | $ | | ||||||||
稀释 | $ | $ | $ | $ | | ||||||||
计算每股净利润时使用的股份： | |||||||||||||
普通股基本加权平均股份 |
| |
| |
| |
| | |||||
普通股稀释加权平均股份 |
| |
| |
| |
| | |||||
请参阅这些未经审核的合并基本报表附注
3
Axcelis Technologies, Inc.
Consolidated Statements of Comprehensive Income
(In thousands)
(Unaudited)
Three months ended | Nine months ended | ||||||||||||
September 30, | September 30, | ||||||||||||
| 2024 |
| 2023 |
| 2024 |
| 2023 |
| |||||
Net income | $ | | $ | | $ | | $ | | |||||
Other comprehensive income (loss): | |||||||||||||
Foreign currency translation adjustments |
| |
| ( |
| ( |
| ( | |||||
Amortization of actuarial net gain and other adjustments from pension plan, net of tax |
| |
| — |
| |
| — | |||||
Total other comprehensive income (loss) | | ( | ( | ( | |||||||||
Comprehensive income | $ | | $ | | $ | | $ | | |||||
See accompanying Notes to these Consolidated Financial Statements (Unaudited)
4
Axcelis Technologies, Inc.
Consolidated Balance Sheets
(In thousands, except per share amounts)
(Unaudited)
| September 30, |
| December 31, |
| |||
2024 | 2023 |
| |||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | | $ | | |||
Short-term investments |
| |
| | |||
Accounts receivable, net |
| |
| | |||
Inventories, net |
| |
| | |||
Prepaid income taxes | | — | |||||
Prepaid expenses and other current assets |
| |
| | |||
Total current assets |
| |
| | |||
Property, plant and equipment, net |
| |
| | |||
Operating lease assets | | | |||||
Finance lease assets, net | | | |||||
Long-term restricted cash |
| |
| | |||
Deferred income taxes | | | |||||
Other assets |
| |
| | |||
Total assets | $ | | $ | | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable | $ | | $ | | |||
Accrued compensation |
| |
| | |||
Warranty |
| |
| | |||
Income taxes |
| — |
| | |||
Deferred revenue |
| |
| | |||
Current portion of finance lease obligation |
| |
| | |||
Other current liabilities |
| |
| | |||
Total current liabilities |
| |
| | |||
Long-term finance lease obligation |
| |
| | |||
Long-term deferred revenue |
| |
| | |||
Other long-term liabilities |
| |
| | |||
Total liabilities |
| |
| | |||
Commitments and contingencies (Note 17) | |||||||
Stockholders’ equity: | |||||||
Common stock, $ |
| |
| | |||
Additional paid-in capital |
| |
| | |||
Retained earnings |
| |
| | |||
Accumulated other comprehensive loss |
| ( |
| ( | |||
Total stockholders’ equity |
| |
| | |||
Total liabilities and stockholders’ equity | $ | | $ | | |||
See accompanying Notes to these Consolidated Financial Statements (Unaudited)
5
Axcelis Technologies, Inc.
Consolidated Statements of Stockholders’ Equity
(In thousands)
(Unaudited)
Accumulated |
| ||||||||||||||||||
Additional | Other | Total |
| ||||||||||||||||
Common Stock | Paid-in | Retained | Comprehensive | Stockholders’ |
| ||||||||||||||
| Shares |
| Amount |
| Capital |
| Earnings |
| (Loss) |
| Equity |
| |||||||
Balance at December 31, 2022 | | $ | | $ | | $ | | $ | ( | $ | | ||||||||
Net income |
| — |
| — |
| — |
| |
| — |
| | |||||||
Foreign currency translation adjustments |
| — |
| — |
| — |
| — |
| |
| | |||||||
Exercise of stock options |
| |
| — |
| |
| — |
| — |
| | |||||||
Issuance of common stock on restricted stock units, net of shares withheld |
| |
| — |
| ( |
| — |
| — |
| ( | |||||||
Stock-based compensation expense | — |
| — |
| |
| — |
| — |
| | ||||||||
Repurchase of common stock |
| ( |
| — |
| ( |
| ( |
| — |
| ( | |||||||
Balance at March 31, 2023 |
| | $ | | $ | | $ | | $ | ( | $ | | |||||||
Net income |
| — |
| — |
| — |
| |
| — |
| | |||||||
Foreign currency translation adjustments |
| — |
| — |
| — |
| — |
| ( |
| ( | |||||||
Issuance of stock under Employee Stock Purchase Plan |
| |
| — |
| |
| — |
| — |
| | |||||||
Issuance of common stock on restricted stock units, net of shares withheld |
| |
| — |
| ( |
| — |
| — |
| ( | |||||||
Stock-based compensation expense | — |
| — |
| |
|
| — |
| | |||||||||
Repurchase of common stock | ( | — | ( | ( | — | ( | |||||||||||||
Balance at June 30, 2023 |
| | $ | | $ | | $ | | $ | ( | $ | | |||||||
Net income |
| — |
| — |
| — |
| |
| — |
| | |||||||
Foreign currency translation adjustments |
| — |
| — |
| — |
| — |
| ( |
| ( | |||||||
Issuance of common stock on restricted stock units, net of shares withheld |
| |
| — |
| ( |
| — |
| — |
| ( | |||||||
Stock-based compensation expense | — |
| — |
| |
| — |
| — |
| | ||||||||
Repurchase of common stock |
| ( |
| — |
| ( |
| ( |
| — |
| ( | |||||||
Balance at September 30, 2023 |
| | $ | | $ | | $ | | $ | ( | $ | | |||||||
See accompanying Notes to these Consolidated Financial Statements (Unaudited)
6
Axcelis Technologies, Inc.
Consolidated Statements of Stockholders’ Equity
(In thousands)
(Unaudited)
Accumulated | ||||||||||||||||||
Additional | Other | Total | ||||||||||||||||
Common Stock | Paid-in | Retained | Comprehensive | Stockholders’ | ||||||||||||||
| Shares |
| Amount |
| Capital |
| Earnings |
| (Loss) |
| Equity | |||||||
Balance at December 31, 2023 | | $ | | $ | | $ | | $ | ( | $ | | |||||||
Net income |
| — |
| — |
| — |
| |
| — |
| | ||||||
Foreign currency translation adjustments |
| — |
| — |
| — |
| — |
| ( |
| ( | ||||||
Change in pension obligation |
| — |
| — |
| — |
| — |
| |
| | ||||||
Issuance of common stock on restricted stock units, net of shares withheld |
| |
| — |
| ( |
| — |
| — |
| ( | ||||||
Stock-based compensation expense | — |
| — |
| |
| — |
| — |
| | |||||||
Repurchase of common stock |
| ( |
| — |
| ( |
| ( |
| — |
| ( | ||||||
Balance at March 31, 2024 |
| | $ | | $ | | $ | | $ | ( | $ | | ||||||
Net income |
| — |
| — |
| — |
| |
| — |
| | ||||||
Foreign currency translation adjustments |
| — |
| — |
| — |
| — |
| ( |
| ( | ||||||
Change in pension obligation |
| — |
| — |
| — |
| — |
| |
| | ||||||
Issuance of stock under Employee Stock Purchase Plan |
| |
| — |
| |
| — |
| — |
| | ||||||
Issuance of common stock on restricted stock units, net of shares withheld |
| |
| — |
| ( |
| — |
| — |
| ( | ||||||
Stock-based compensation expense |
| — |
| — |
| |
|
| — |
| | |||||||
Repurchase of common stock | ( | — | ( | ( | — | ( | ||||||||||||
Balance at June 30, 2024 |
| | $ | | $ | | $ | | $ | ( | $ | | ||||||
Net income |
| — |
| — |
| — |
| |
| — |
| | ||||||
Foreign currency translation adjustments |
| — |
| — |
| — |
| — |
| |
| | ||||||
Change in pension obligation |
| — |
| — |
| — |
| — |
| |
| | ||||||
Issuance of common stock on restricted stock units, net of shares withheld |
| |
| — |
| ( |
| — |
| — |
| ( | ||||||
Stock-based compensation expense | — |
| — |
| |
| — |
| — |
| | |||||||
Repurchase of common stock |
| ( |
| — |
| ( |
| ( |
| — |
| ( | ||||||
Balance at September 30, 2024 |
| | $ | | $ | | $ | | $ | ( | $ | | ||||||
See accompanying Notes to these Consolidated Financial Statements (Unaudited)
7
Axcelis Technologies, Inc.
Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
Nine months ended | |||||||
September 30, | |||||||
| 2024 |
| 2023 |
| |||
Cash flows from operating activities | |||||||
Net income | $ | | $ | | |||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Depreciation and amortization |
| |
| | |||
Deferred income taxes |
| ( |
| ( | |||
Stock-based compensation expense |
| |
| | |||
Provision for doubtful accounts | | | |||||
Provision for excess and obsolete inventory |
| |
| | |||
Accretion of discounts and premiums on marketable securities | ( | ( | |||||
Unrealized currency (gain) loss on foreign denominated transactions | ( | | |||||
Mark-to-market adjustment on forward exchange contracts | | — | |||||
Changes in operating assets and liabilities: | |||||||
Accounts receivable |
| |
| ( | |||
Inventories |
| |
| ( | |||
Prepaid expenses and other current assets |
| ( |
| ( | |||
Accounts payable and other current liabilities |
| ( |
| ( | |||
Deferred revenue |
| ( |
| | |||
Income taxes |
| ( |
| ( | |||
Other assets and liabilities |
| ( |
| ( | |||
Net cash provided by operating activities |
| |
| | |||
Cash flows from investing activities | |||||||
Expenditures for property, plant and equipment and capitalized software |
| ( |
| ( | |||
Purchase of short-term investments |
| ( |
| ( | |||
Maturities of short-term investments |
| |
| | |||
Net cash used in investing activities |
| ( |
| ( | |||
Cash flows from financing activities | |||||||
Net settlement on restricted stock grants |
| ( |
| ( | |||
Repurchase of common stock |
| ( |
| ( | |||
Proceeds from Employee Stock Purchase Plan purchases |
| |
| | |||
Principal payments on finance lease obligation | ( | ( | |||||
Proceeds from exercise of stock options | — | | |||||
Net cash used in financing activities |
| ( |
| ( | |||
Effect of exchange rate changes on cash and cash equivalents |
| ( |
| ( | |||
Net decrease in cash, cash equivalents and restricted cash |
| ( |
| ( | |||
Cash, cash equivalents and restricted cash at beginning of period |
| |
| | |||
Cash, cash equivalents and restricted cash at end of period | $ | | $ | | |||
See accompanying Notes to these Consolidated Financial Statements (Unaudited)
8
Axcelis Technologies, Inc.
Notes to Consolidated Financial Statements (Unaudited)
Note 1. Nature of Business
Axcelis Technologies, Inc. (“Axcelis” or the “Company”) was incorporated in Delaware in 1995 and is a producer of ion implantation equipment used in the fabrication of semiconductor chips in the United States, Europe and Asia. In addition, we provide extensive worldwide aftermarket service and support, including spare parts, equipment upgrades, used equipment, and maintenance services to the semiconductor industry.
The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments which are of a normal recurring nature and considered necessary for a fair presentation of these financial statements have been included. Operating results for the interim periods presented are not necessarily indicative of the results that may be expected for other interim periods or for the year as a whole.
The balance sheet at December 31, 2023 has been derived from the audited consolidated financial statements at that date but does not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. As of September 30, 2024, there have been no material changes in the Company’s significant accounting policies, other than with respect to the Company’s accounting policy for derivative financial instruments, which it had not held in prior periods, as described in Note 2 below. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission (the “SEC”) on February 23, 2024, as amended by Amendment No. 1 thereto, filed with the SEC on February 28, 2024 (as so amended, the “2023 Form 10-K”).
Note 2. Significant Accounting Policies
Derivative instruments
We are exposed to certain risks relating to our ongoing business operations, including market risks relating to fluctuations in foreign currency exchange rates. We have entered into forward exchange contracts in order to mitigate risks associated with fluctuations in exchange rates on forecasted transactions denominated in foreign currencies and to minimize the impact of foreign currency fluctuations on our earnings and cash flows. These contracts have month-to-month settlement dates. As of September 30, 2024, we had open contracts with a notional value of $
We do not offset fair value amounts of derivative instruments. We do not use derivative instruments for speculative purposes.
Note 3. Stock-Based Compensation
We maintain the Axcelis Technologies, Inc. 2012 Equity Incentive Plan, as amended (the “2012 Equity Plan”), which became effective on May 2, 2012, and permits the issuance of options, restricted stock, restricted stock units (“RSUs”) and performance awards to selected employees, directors, and consultants of the Company.
The 2012 Equity Plan is more fully described in Note 13 to the consolidated financial statements in our 2023 Form 10-K.
9
We recognized stock-based compensation expense of $
In the three-month periods ended September 30, 2024 and 2023, we issued
In the nine-month periods ended September 30, 2024 and 2023, we issued
Note 4. Leases
We have operating leases for manufacturing, office space, warehouse space, computer and office equipment and vehicles used in our business operations. We have a finance lease in relation to the 2015 sale-leaseback of our corporate headquarters in Beverly, Massachusetts. We review all agreements to determine if the agreement contains a lease component. An agreement contains a lease component if it provides for the use of a specific physical space or a specific physical item.
We recognize operating lease obligations under Accounting Standards Codification Topic 842, Leases (“Topic 842”). The guidance in Topic 842 requires recognition of lease assets and related liabilities on a discounted basis using the explicit or implicit discount rate stated within the agreement. We recognize a corresponding right-of-use asset, which is initially determined based upon the net present value of the associated liability and is adjusted for deferred costs and possible impairment, if any. For those lease agreements that do not indicate the applicable discount rate, we use our incremental borrowing rate. We have made the following policy elections: (i) operating leases with an initial term of 12 months or less are not recorded on the consolidated balance sheets; (ii) we recognize lease expense for operating leases on a straight-line basis over the lease term; and (iii) we account for lease components and non-lease components that are fixed payments as one component. Some of our operating leases include one or more , with renewal terms that can extend the respective lease term by to
10
September 30, | December 31, | |||||||||
Leases | Classification | 2024 |
| 2023 |
|
| ||||
Assets | (in thousands) |
| ||||||||
Operating lease assets | $ | | $ | | ||||||
Finance lease assets* |
| |
| | ||||||
Total leased assets | $ | | $ | | ||||||
Liabilities | ||||||||||
Current | ||||||||||
Other current liabilities | $ | | $ | | ||||||
Current portion of finance lease obligation | | | ||||||||
Non-current | ||||||||||
Other long-term liabilities | | | ||||||||
Finance lease obligation |
| |
| | ||||||
$ | | $ | | |||||||
*Finance lease assets are recorded net of accumulated depreciation of $ | ||||||||||
11
Our operating lease office locations support local selling and servicing functions. Our Axcelis Asia Operations Center facility in South Korea is used to manufacture our products for Asia-based customers. We lease a logistics and flex manufacturing center in Beverly, Massachusetts to support our principal product manufacturing operations at our corporate headquarters. Operating lease expense and depreciation and interest expense relating to our finance lease obligation are recognized within our Consolidated Statement of Operations for the three and nine months ended September 30, 2024 and 2023 as follows:
Three months ended | Nine months ended |
| |||||||||||||
September 30, | September 30, | ||||||||||||||
Lease cost | Classification | 2024 |
| 2023 |
| 2024 |
| 2023 |
| ||||||
Operating lease cost | (in thousands) |
| |||||||||||||
Product / services* | Cost of revenue | $ | | $ | | $ | | $ | | ||||||
Research and development | Operating expenses |
| |
| |
| |
| | ||||||
Sales and marketing* | Operating expenses |
| |
| |
| |
| | ||||||
General and administrative* | Operating expenses |
| |
| |
| |
| | ||||||
Total operating lease cost | $ | | $ | | $ | | $ | | |||||||
Finance lease cost | |||||||||||||||
Depreciation of leased assets | Cost of revenue, Research and development, Sales and marketing and General and administrative | $ | | $ | | $ | | $ | | ||||||
Interest on lease liabilities | Interest expense |
| |
| |
| |
| | ||||||
Total finance lease cost | $ | | $ | | $ | | $ | | |||||||
Total lease cost | $ | | $ | | $ | | $ | | |||||||
* Product / services, sales and marketing and general and administrative expense also includes short-term lease and variable lease costs of approximately $ | |||||||||||||||
The lease of our corporate headquarters, shown below under finance leases, had an original lease term of
Finance | Operating |
| Total |
| ||||||
Maturity of Lease Liabilities | Leases | Leases | Leases | |||||||
(in thousands) | ||||||||||
2024 | $ | | $ | | $ | | ||||
2025 |
| |
| |
| | ||||
2026 |
| |
| |
| | ||||
2027 |
| |
| |
| | ||||
2028 | | | | |||||||
Thereafter | | | | |||||||
Total lease payments | $ | | $ | | $ | | ||||
Less interest portion* | ( | ( | ( | |||||||
Finance lease and operating lease obligations | $ | | $ | | $ | | ||||
* Finance lease interest calculated using the implied interest rate; operating lease interest calculated using estimated corporate borrowing rate. | ||||||||||
The table above does not include options to renew lease terms that are not reasonably certain of being exercised.
12
September 30, | ||||
Lease term and discount rate |
| 2024 | ||
Weighted-average remaining lease term (years): | ||||
Operating leases | ||||
Finance leases |
| |||
Weighted-average discount rate: | ||||
Operating leases |
| |||
Finance leases |
| |||
Our cash outflows from our operating leases include rent expense and other charges associated with these leases. These cash flows are included within the operating activities section of our statement of cash flows. Our cash flows from our finance lease include both an interest component and a principal component. The table below shows our cash outflows by lease type and related section of our statement of cash flows, as well as the non-cash amount capitalized on our balance sheet in relation to our operating lease right-of-use assets for the nine months ended September 30, 2024 and 2023, respectively:
Nine months ended September 30, | ||||||
Cash paid for amounts included in the measurement of lease liabilities |
| 2024 |
| 2023 | ||
(in thousands) | ||||||
Operating cash outflows from operating leases | $ | | $ | | ||
Operating cash outflows from finance leases |
| |
| | ||
Financing cash outflows from finance leases |
| |
| | ||
Operating lease assets obtained in exchange for operating lease liabilities |
| |
| | ||
Finance lease assets obtained in exchange for new finance lease liabilities |
| — |
| — | ||
Note 5. Revenue
To reflect the organization of our business operations, we divide revenue into two categories: revenue from sales of new systems and revenue arising from the sale of used systems, parts, and labor to customers who own systems, which we refer to as “Aftermarket.”
Revenue by categories used by management are as follows:
Three months ended | Nine months ended | |||||||||||
September 30, | September 30, | |||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||
(in thousands) | ||||||||||||
Systems | $ | $ | $ | $ | ||||||||
Aftermarket | | | | | ||||||||
Total Revenue | $ | $ | $ | $ | ||||||||
13
We also consider revenue by geography. Revenue is allocated to geographic markets based upon the location to which our products are shipped and in which our services are performed. Revenue in our principal geographic markets is as follows:
Three months ended | Nine months ended | |||||||||||
September 30, | September 30, | |||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||
(in thousands) | ||||||||||||
North America | $ | $ | $ | $ | ||||||||
Asia Pacific | ||||||||||||
Europe | ||||||||||||
Total Revenue | $ | $ | $ | $ | ||||||||
Our system sales revenue transactions give rise to contract liabilities (in the case of pre-payments and the fair value of goods and services to be delivered after the system delivery, such as installation and certain warranty obligations).
Contract liabilities are as follows:
September 30, | December 31, | |||||
2024 | 2023 | |||||
(in thousands) | ||||||
Contract liabilities | $ | | $ | | ||
Contract liabilities are reflected as deferred revenue on the consolidated balance sheets and include payments received in advance of system sales as well as deferral of revenue from systems sales for installation and other future performance obligations. Contract liabilities are recognized as revenue upon the fulfillment of performance obligations.
Three months ended | Nine months ended | |||||||||||
September 30, |
| September 30, | ||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||
(in thousands) | ||||||||||||
Balance, beginning of the period | $ | | $ | | $ | | $ | | ||||
Deferral of revenue* | | | | | ||||||||
Recognition of deferred revenue | ( | ( | ( | ( | ||||||||
Balance, end of the period | $ | | $ | | $ | | $ | | ||||
* Amount is net of a reclassification of $
The majority of our system transactions have either (1) payment terms of
Note 6. Receivables and Allowances for Credit Losses
All trade receivables are reported on the consolidated balance sheets at their amortized cost adjusted for any write-offs and net of allowances for credit losses.
We maintain an allowance for credit losses, which represents an estimate of expected losses over the remaining contractual life of our receivables, considering current market conditions and estimates for supportable forecasts when appropriate. The estimate is a result of our ongoing assessments and evaluations of collectability, historical loss experience, and future expectations in estimating credit losses in our receivable portfolio. We use historical loss experience rates and apply them to a related aging analysis while also considering customer and/or economic risk where appropriate. Determination of the proper amount of allowances requires management to exercise judgment about the timing, frequency and severity of credit losses that could materially affect the provision for credit losses and, as a result, net earnings. The
14
allowance takes into consideration numerous quantitative and qualitative factors that include receivable type, historical loss experience, loss migration, delinquency trends, collection experience, current economic conditions, trade restrictions, estimates for supportable forecasts, when appropriate, and credit risk characteristics.
We evaluate the credit risk of the customer when extending credit based on a combination of financial and qualitative factors that may affect our customers’ ability to pay. These factors may include the customer’s financial condition, past payment experience, and credit bureau report, as well as the value of the underlying collateral.
Management performs detailed reviews of our receivables on a quarterly basis to assess the adequacy of the allowances and to determine if any impairment has occurred. Amounts determined to be uncollectable are charged directly against the allowances, while amounts recovered on previously written-off accounts increase the allowances. Changes to the allowances for credit losses are maintained through adjustments to the provision for credit losses, which are charged to current period earnings. We recorded $
Note 7. Computation of Net Earnings per Share
Basic earnings per share is computed by dividing income available to common stockholders (the numerator) by the weighted-average number of shares of common stock outstanding (the denominator) for the period. The computation of diluted earnings per share is similar to basic earnings per share, except that the denominator is increased by the number of additional shares of common stock that would have been outstanding if the potentially dilutive shares of common stock issuable on exercise of stock options and vesting of RSUs had been issued, calculated using the treasury stock method.
The components of net earnings per share are as follows:
Three months ended | Nine months ended | ||||||||||||
September 30, | September 30, | ||||||||||||
| 2024 |
| 2023 |
| 2024 |
| 2023 |
| |||||
(in thousands, except per share amounts) | |||||||||||||
Net income available to common stockholders | $ | | $ | | $ | | $ | | |||||
Weighted average shares of common stock outstanding used in computing basic income per share |
| |
| |
| |
| | |||||
Incremental options and RSUs |
| |
| |
| |
| | |||||
Weighted average shares of common stock used in computing diluted net income per share |
| |
| |
| |
| | |||||
Net income per share | |||||||||||||
Basic | $ | | $ | | $ | | $ | | |||||
Diluted | $ | | $ | | $ | | $ | | |||||
Diluted weighted average shares of common stock outstanding does not include
15
Note 8. Accumulated Other Comprehensive Loss
The following table presents the changes in accumulated other comprehensive loss, net of tax, by component, for the nine months ended September 30, 2024:
| Foreign |
| Defined benefit |
|
| |||||
currency | pension plan | Total |
| |||||||
(in thousands) |
| |||||||||
Balance at December 31, 2023 | $ | ( | $ | | $ | ( | ||||
Other comprehensive loss and pension reclassification |
| ( |
| |
| ( | ||||
Balance at September 30, 2024 | $ | ( | $ | | $ | ( | ||||
Note 9. Cash, cash equivalents and restricted cash
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets to the total of the amounts shown in the statement of cash flows:
September 30, | December 31, | |||||
2024 | 2023 | |||||
(in thousands) | ||||||
Cash and cash equivalents | $ | $ | ||||
Long-term restricted cash | ||||||
Total cash, cash equivalents and restricted cash | $ | $ | ||||
As of September 30, 2024, we had $
Note 10. Inventories, net
The components of inventories are as follows:
September 30, | December 31, | ||||||
| 2024 |
| 2023 |
| |||
(in thousands) | |||||||
Raw materials | $ | | $ | | |||
Work in process |
| |
| | |||
Finished goods (completed systems) |
| |
| | |||
Inventories, net | $ | | $ | | |||
When recorded, inventory reserves reduce the carrying value of inventories to their net realizable value. We establish inventory reserves when conditions exist that indicate inventory may be in excess of anticipated demand or is obsolete based upon assumptions about future demand for our products or market conditions. We regularly evaluate the ability to realize the value of inventories based on a combination of factors including the following: forecasted sales or usage, estimated product end of life dates, estimated current and future market value and new product introductions. Purchasing and usage alternatives are also explored to mitigate inventory exposure.
Note 11. Product Warranty
We generally offer a
16
The changes in our standard product warranty liability are as follows:
Nine months ended | |||||||
September 30, | |||||||
| 2024 |
| 2023 |
| |||
(in thousands) | |||||||
Balance at January 1 (beginning of year) | $ | | $ | | |||
Warranties issued during the period |
| |
| | |||
Settlements made during the period |
| ( |
| ( | |||
Changes in estimate of liability for pre-existing warranties during the period |
| ( |
| | |||
Balance at September 30 (end of period) | $ | | $ | | |||
Amount classified as current | $ | | $ | | |||
Amount classified as long-term (within other long-term liabilities) |
| |
| | |||
Total warranty liability | $ | | $ | | |||
Note 12. Fair Value Measurements
Fair value is defined as the price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.
(a) Fair Value Hierarchy
The accounting guidance for fair value measurement requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is as follows:
Level 1 - applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.
Level 2 - applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability, such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.
Level 3 - applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
(b) Fair Value Measurements
Our money market funds and short-term investments with initial maturities of three months or less are included in cash and cash equivalents in the consolidated balance sheets. Other investments that have a maturity of greater than three months but less than one year are included within short-term investments in the consolidated balance sheets.
17
The following table sets forth our assets by level within the fair value hierarchy:
September 30, 2024 |
| ||||||||||||
Fair Value Measurements |
| ||||||||||||
| Level 1 |
| Level 2 |
| Level 3 |
| Total |
| |||||
(in thousands) |
| ||||||||||||
Assets | |||||||||||||
Cash equivalents and other short-term investments: | |||||||||||||
Cash equivalents (money market funds, U.S. Government Securities and Agency Investments) | $ | | $ | — | $ | — | $ | | |||||
Short-term investments (U.S. Government Securities and Agency Investments) | | — | — | | |||||||||
Mark-to-market adjustment on forward exchange contracts | — | ( | — | ( | |||||||||
Total | $ | | $ | ( | $ | — | $ | | |||||
December 31, 2023 |
| ||||||||||||
Fair Value Measurements |
| ||||||||||||
| Level 1 |
| Level 2 |
| Level 3 |
| Total |
| |||||
(in thousands) |
| ||||||||||||
Assets | |||||||||||||
Cash equivalents and other short-term investments: | |||||||||||||
Cash equivalents (money market funds, U.S. Government Securities and Agency Investments) | $ | | $ | — | $ | — | $ | | |||||
Short-term investments (U.S. Government Securities and Agency Investments) | | — | — | | |||||||||
Total | $ | | $ | — | $ | — | $ | | |||||
(c) Other Financial Instruments
The carrying amounts reflected in the consolidated balance sheets for accounts receivable, prepaid expenses, forward currency exchange contracts and other current assets and non-current assets, restricted cash, accounts payable and accrued expenses approximate fair value due to their short-term maturities.
(d) Forward Currency Exchange Contracts
Beginning in February 2024, we entered into forward currency exchange contracts to minimize the impact of foreign currency fluctuations on our earnings and cash flows. These contracts have month-to-month settlement dates. Any gains or losses on these contracts are reported within Other, net in our Consolidated Statement of Operations. Any open contracts at period end that have settlement dates within one month after the reported period end and any mark-to-market valuation adjustments related to these open contracts are recorded in the current asset or current liability account and any unrealized gain or loss recognized is recorded within Other, net in our Consolidated Statement of Operations. These contracts are measured at fair value using observable market inputs such as forward currency exchange rates and our counterparties’ credit risks. Based on these inputs, the derivative instruments are classified within Level 2 of the valuation hierarchy. At September 30, 2024, the recognized unrealized loss on these forward exchange contracts was approximately $
Note 13. Financing Arrangements
On January 30, 2015, we sold our corporate headquarters facility in Beverly, Massachusetts for $
18
As of September 30, 2024, we had a security deposit of $
Note 14. Income Taxes
Income tax expense was $
The effective tax rate for the three and nine months ended September 30, 2024 was less than the U.S. statutory rate of
The deferred income taxes of $
Note 15. Concentration of Risk
For the three months ended September 30, 2024,
For the nine months ended September 30, 2024,
At September 30, 2024,
Note 16. Share Repurchase
In February 2022, our Board of Directors approved stock repurchases of up to $
Repurchased shares are accounted for when the transaction is settled and returned to the status of authorized but unissued shares. Accordingly, on our balance sheet, the repurchase price is deducted from common stock par value and from additional paid-in capital for the excess over par value. If additional paid-in capital has been exhausted, the excess over par value is deducted from retained earnings. Direct costs incurred to acquire the shares are included in the total cost of the shares.
Note 17. Contingencies
(a) Litigation
We are from time to time a party to litigation that arises in the normal course of our business operations. We are not presently a party to any litigation that we believe might have a material adverse effect on our business operations.
19
(b) Indemnifications
Our system sales agreements typically include provisions under which we agree to take certain actions, provide certain remedies and defend our customers against third-party claims of intellectual property infringement under specified conditions and indemnify customers against any damage and costs awarded in connection with such claims. We have not incurred any material costs as a result of such indemnifications and have not accrued any liabilities related to such obligations in the accompanying consolidated financial statements.
Note 18. Recent Accounting Guidance
In November 2023 the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). ASU 2023-07 is intended to enhance disclosures for significant segment expenses for all public entities required to report segment information in accordance with ASC Topic 280, Segment Reporting (“ASC 280”). ASC 280 requires a public entity to report for each reportable segment a measure of segment profit or loss that its chief operating decision maker (“CODM”) uses to assess segment performance and to make decisions about resource allocations. ASU 2023-07 is intended to improve financial reporting by requiring disclosure of incremental segment information on an annual and interim basis for all public entities to enable investors to develop more useful financial analyses. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. A public entity should apply ASU 2023-07 retrospectively to all prior periods presented in the consolidated financial statements. We are currently evaluating the impact of ASU 2023-07 on our future consolidated financial statements and related disclosures.
In December 2023 the FASB issued Accounting Standards Update 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 is intended to enhance the transparency and decision usefulness of income tax disclosures. ASU 2023-09 addresses investor requests for enhanced income tax information primarily through changes to the rate reconciliation and income taxes paid information. Early adoption is permitted. A public entity should apply ASU 2023-09 prospectively to all annual periods beginning after December 15, 2024. We are currently evaluating the impact of ASU 2023-09 on our future consolidated financial statements and related disclosures.
20
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Certain statements within "Management's Discussion and Analysis of Financial Condition and Results of Operations" are forward-looking statements that involve risks and uncertainties. Words such as may, will, should, would, anticipates, expects, intends, plans, believes, seeks, estimates and similar expressions identify such forward-looking statements. The forward-looking statements contained herein are based on current expectations and entail various risks and uncertainties that could cause actual results to differ materially from those expressed in such forward-looking statements. Factors that might cause such a difference include, among other things, those set forth under "Liquidity and Capital Resources" below and under “Risk Factors” in Part I, Item 1A to our 2023 Form 10-K, which discussion is incorporated herein by reference. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. We assume no obligation to update these forward-looking statements to reflect actual results or changes in factors or assumptions affecting forward-looking statements, except as may be required by law.
Overview
We are primarily a producer of ion implantation equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. In addition, we provide extensive worldwide aftermarket service and support, including spare parts, equipment upgrades and maintenance services to the semiconductor industry. Our product development and manufacturing activities currently occur primarily in the United States and South Korea. Our equipment and service products are highly technical and are sold through a direct sales force in the United States, Europe, and Asia. Consolidation and partnering within the semiconductor manufacturing industry has resulted in a small number of customers representing a substantial portion of our business. Our ten largest customers accounted for 48.2% of total revenue for the nine months ended September 30, 2024.
Demand for our capital equipment in the first nine months of 2024 has been relatively flat. The overall mature process segment represented 98% of our shipped systems revenue, with 1% of shipments to advanced logic and 1% of shipments to dynamic random-access memory (“DRAM”). Power device shipments comprised 58% of total systems revenue with the general mature segment representing 32%, and image sensors at 9%.
Critical Accounting Estimates
Management’s discussion and analysis of our financial condition and results of operations included herein and in our 2023 Form 10-K are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates and assumptions. Management’s estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
Management has not identified any need to make any material change in, and has not changed, any of our critical accounting estimates and judgments as described in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our 2023 Form 10-K.
21
Results of Operations
The following table sets forth our results of operations as a percentage of total revenue:
Three months ended | Nine months ended | ||||||||||
September 30, | September 30, | ||||||||||
| 2024 |
| 2023 |
|
| 2024 |
| 2023 |
|
| |
Revenue: | |||||||||||
Product | 96.2 | % | 96.9 | % | 96.1 | % | 96.9 | % | |||
Services |
| 3.8 |
| 3.1 |
|
| 3.9 |
| 3.1 |
|
|
Total revenue |
| 100.0 |
| 100.0 |
|
| 100.0 |
| 100.0 |
|
|
Cost of revenue: | |||||||||||
Product |
| 53.2 |
| 53.0 |
|
| 52.1 |
| 54.2 |
|
|
Services |
| 4.0 |
| 2.7 |
|
| 3.7 |
| 2.8 |
|
|
Total cost of revenue |
| 57.2 |
| 55.7 |
|
| 55.8 |
| 57.0 |
|
|
Gross profit |
| 42.8 |
| 44.3 |
|
| 44.2 |
| 43.0 |
|
|
Operating expenses: | |||||||||||
Research and development |
| 10.3 |
| 8.2 |
|
| 10.2 |
| 8.8 |
|
|
Sales and marketing |
| 6.6 |
| 5.6 |
|
| 6.7 |
| 5.6 |
|
|
General and administrative |
| 7.7 |
| 6.0 |
|
| 6.9 |
| 5.9 |
|
|
Total operating expenses |
| 24.6 |
| 19.8 |
|
| 23.8 |
| 20.3 |
|
|
Income from operations |
| 18.2 |
| 24.5 |
|
| 20.4 |
| 22.7 |
|
|
Other income (expense): | |||||||||||
Interest income |
| 2.6 |
| 1.6 |
|
| 2.4 |
| 1.6 |
|
|
Interest expense |
| (0.5) |
| (0.5) |
|
| (0.5) |
| (0.5) |
|
|
Other, net |
| 1.3 |
| (0.4) |
|
| 0.2 |
| (0.5) |
|
|
Total other income |
| 3.4 |
| 0.7 |
|
| 2.1 |
| 0.6 |
|
|
Income before income taxes |
| 21.6 |
| 25.2 |
|
| 22.5 |
| 23.3 |
|
|
Income tax provision |
| 2.6 |
| 2.6 |
|
| 2.7 |
| 1.9 |
|
|
Net income | 19.0 | % | 22.6 | % | 19.8 | % | 21.4 | % | |||
Revenue
The following table sets forth our product and services revenue:
Three months ended | Period-to-Period | Nine months ended | Period-to-Period |
| ||||||||||||||||||||
September 30, | Change | September 30, | Change |
| ||||||||||||||||||||
2024 | 2023 | $ | % | 2024 | 2023 | $ | % |
| ||||||||||||||||
(dollars in thousands) | ||||||||||||||||||||||||
Revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||
Product | $ | 246,826 | $ | 283,367 | $ | (36,541) | (12.9) | % | $ | 735,626 | $ | 795,047 | $ | (59,421) | (7.5) | % | ||||||||
Percentage of revenue | 96.2 | % | 96.9 | % | 96.1 | % | 96.9 | % | ||||||||||||||||
Services |
| 9,738 |
| 8,959 | 779 | 8.7 | % |
| 29,822 |
| 25,269 | 4,553 | 18.0 | % | ||||||||||
Percentage of revenue | 3.8 | % | 3.1 | % | 3.9 | % | 3.1 | % | ||||||||||||||||
Total revenue | $ | 256,564 | $ | 292,326 | $ | (35,762) | (12.2) | % | $ | 765,448 | $ | 820,316 | $ | (54,868) | (6.7) | % | ||||||||
Three months ended September 30, 2024 Compared with Three months ended September 30, 2023
Product
Product revenue, which includes systems sales, sales of spare parts, product upgrades and used systems, was $246.8 million, or 96.2% of revenue, during the three months ended September 30, 2024, compared with $283.4 million, or 96.9% of revenue, for the three months ended September 30, 2023. The $36.5 million decrease in product revenue for the
22
three-month period ended September 30, 2024, in comparison to the same period in 2023, was primarily driven by a decrease in system sales.
Deferred revenue includes payments received in advance of system sales as well as deferral of revenue from systems sales for installation and other future performance obligations. The total amount of deferred revenue at September 30, 2024 and December 31, 2023 was $164.0 million and $210.9 million, respectively.
Services
Services revenue, which includes the labor component of maintenance and service contracts and fees for service hours provided by on-site service personnel, was $9.7 million, or 3.8% of revenue, for the three months ended September 30, 2024, compared with $9.0 million, or 3.1% of revenue, for the three months ended September 30, 2023. Although services revenue typically increases with the expansion of the installed base of systems, it can fluctuate from period to period based on capacity utilization at customers’ manufacturing facilities, which affects the need for equipment service.
Nine months ended September 30, 2024 Compared with Nine months ended September 30, 2023
Product
Product revenue was $735.6 million, or 96.1% of revenue, during the nine months ended September 30, 2024, compared with $795.0 million, or 96.9% of revenue, for the nine months ended September 30, 2023. The $59.4 million decrease in product revenue for the nine-month period ended September 30, 2024, in comparison to the same period in 2023, was primarily driven by a decrease in system sales.
Services
Services revenue was $29.8 million, or 3.9% of revenue, for the nine months ended September 30, 2024, compared with $25.3 million, or 3.1% of revenue, for the nine months ended September 30, 2023.
Revenue Categories used by Management
In addition to the line item revenue categories discussed above, management also regularly disaggregates revenue in the following categories, which it finds relevant and useful:
| ● | Systems and Aftermarket revenues, in which “Aftermarket” is: |
| A. | The portion of Product revenue relating to spare parts, product upgrades and used equipment, combined with |
| B. | Services revenue, which is the labor component of Aftermarket revenues; |
(Aftermarket purchases reflect current fab utilization as opposed to Systems purchases which reflect capital investment decisions by our customers, which have differing economic drivers);
| ● | Revenue by geographic regions, since economic factors impacting customer purchasing decisions may vary by geographic region; and |
| ● | Revenue by our customer market segments, since they can be subject to different economic drivers at different periods of time, impacting a customer’s likelihood of purchasing capital equipment during any particular period. Currently, management references three customer market segments: memory, mature process technology and leading edge foundry and logic. |
23
Aftermarket and Systems Revenue
Three months ended September 30, 2024 Compared with Three months ended September 30, 2023
Included in total revenue of $256.6 million during the three months ended September 30, 2024 is revenue from our Aftermarket business of $55.5 million, compared with $60.9 million of Aftermarket revenue for the three months ended September 30, 2023. Aftermarket revenue fluctuates from period to period based on capacity utilization at customers’ manufacturing facilities, which affects the sale of spare parts and demand for equipment service. Aftermarket revenue can also fluctuate from period to period based on the demand for system upgrades or used equipment. The remaining $201.1 million of revenue for the three months ended September 30, 2024 was systems revenue, compared with $231.4 million of systems revenue for the three months ended September 30, 2023. Systems revenue fluctuates from period to period based on our customers’ capital spending.
Nine months ended September 30, 2024 Compared with Nine months ended September 30, 2023
Included in total revenue of $765.4 million during the nine months ended September 30, 2024 is revenue from our Aftermarket business of $170.3 million, compared with $178.5 million of Aftermarket revenue for the nine months ended September 30, 2023. The remaining $595.1 million of revenue for the nine months ended September 30, 2024 was systems revenue, compared with $641.8 million of systems revenue for the nine months ended September 30, 2023.
Gross Profit / Gross Margin
The following table sets forth our gross profit / gross margin:
Three months ended | Period-to-Period | Nine months ended | Period-to-Period |
| ||||||||||||||||||||
September 30, | Change | September 30, | Change |
| ||||||||||||||||||||
| 2024 |
| 2023 |
| $ | % |
| 2024 |
| 2023 |
| $ | % |
|
| |||||||||
(dollars in thousands) | ||||||||||||||||||||||||
Gross Profit: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||
Product | $ | 110,447 | $ | 128,569 | $ | (18,122) | (14.1) | % | $ | 336,577 | $ | 350,736 | $ | (14,159) | (4.0) | % | ||||||||
Product gross margin | 44.7 | % | 45.4 | % | 45.8 | % | 44.1 | % | ||||||||||||||||
Services |
| (477) |
| 1,115 | (1,592) | (142.8) | % |
| 1,854 | 2,669 | (815) | (30.5) | % | |||||||||||
Services gross margin | (4.9) | % | 12.4 | % | 6.2 | % | 10.6 | % | ||||||||||||||||
Total gross profit | $ | 109,970 | $ | 129,684 | $ | (19,714) | (15.2) | % | $ | 338,431 | $ | 353,405 | $ | (14,974) | (4.2) | % | ||||||||
Gross margin | 42.8 | % | 44.3 | % | 44.2 | % | 43.0 | % | ||||||||||||||||
Three months ended September 30, 2024 Compared with Three months ended September 30, 2023
Product
Gross margin from product revenue was 44.7% for the three months ended September 30, 2024, compared to 45.4% for the three months ended September 30, 2023. The decrease in gross margin primarily resulted from an unfavorable mix of system revenue.
Services
Gross margin from services revenue was (4.9)% for the three months ended September 30, 2024, compared to 12.4% for the three months ended September 30, 2023. The decrease in gross margin is attributable to changes in the mix of service contracts.
24
Nine months ended September 30, 2024 Compared with Nine months ended September 30, 2023
Product
Gross margin from product revenue was 45.8% for the nine months ended September 30, 2024, compared to 44.1% for the nine months ended September 30, 2023. The increase in gross margin primarily resulted from a favorable mix of system revenue.
Services
Gross margin from services revenue was 6.2% for the nine months ended September 30, 2024, compared to 10.6% for the nine months ended September 30, 2023. The decrease in gross margin is attributable to changes in the mix of service contracts.
Operating Expenses
The following table sets forth our operating expenses:
Three months ended | Period-to-Period | Nine months ended | Period-to-Period |
| ||||||||||||||||||||
September 30, | Change | September 30, | Change |
| ||||||||||||||||||||
2024 | 2023 | $ | % | 2024 | 2023 | $ | % |
| ||||||||||||||||
(dollars in thousands) | ||||||||||||||||||||||||
Research and development |
| $ | 26,395 |
| $ | 24,093 |
| $ | 2,302 |
| 9.6 | % | $ | 77,843 |
| $ | 71,996 |
| $ | 5,847 |
| 8.1 | % |
|
Percentage of revenue | 10.3 | % | 8.2 | % | 10.2 | % | 8.8 | % | ||||||||||||||||
Sales and marketing |
| 16,808 |
| 16,465 | 343 | 2.1 | % |
| 51,483 |
| 46,146 | 5,337 | 11.6 | % | ||||||||||
Percentage of revenue | 6.6 | % | 5.6 | % | 6.7 | % | 5.6 | % | ||||||||||||||||
General and administrative |
| 19,854 |
| 17,446 | 2,408 | 13.8 | % |
| 52,842 |
| 48,519 | 4,323 | 8.9 | % | ||||||||||
Percentage of revenue | 7.7 | % | 6.0 | % | 6.9 | % | 5.9 | % | ||||||||||||||||
Total operating expenses | $ | 63,057 | $ | 58,004 | $ | 5,053 | 8.7 | % | $ | 182,168 | $ | 166,661 | $ | 15,507 | 9.3 | % | ||||||||
Percentage of revenue | 24.6 | % | 19.8 | % | 23.8 | % | 20.3 | % | ||||||||||||||||
Our operating expenses consist primarily of personnel costs, including wages, commissions, incentive-based compensation, stock-based compensation and related benefits and taxes; project material costs related to the design and development of new products and enhancement of existing products; and professional fees, travel and depreciation expenses.
Personnel costs are our largest expense, representing $35.5 million, or 56.3%, of our total operating expenses for the three months ended September 30, 2024, compared to $34.8 million, or 60.0%, of our total operating expenses for the three months ended September 30, 2023. Personnel costs were $107.2 million, or 58.9%, of our total operating expenses for the nine months ended September 30, 2024, compared to $99.3 million, or 59.6%, of our total operating expenses for the nine months ended September 30, 2023. The higher personnel costs for the three and nine months ended September 30, 2024 are primarily due to increases in wages and headcount as well as stock compensation expense, partially offset by a decrease in variable compensation expense.
Research and Development
Three months ended | Period-to-Period | Nine months ended | Period-to-Period |
| ||||||||||||||||||||||
September 30, | Change | September 30, | Change |
| ||||||||||||||||||||||
2024 | 2023 | $ | % | 2024 | 2023 | $ | % |
| ||||||||||||||||||
(dollars in thousands) | ||||||||||||||||||||||||||
Research and development |
| $ | 26,395 |
| $ | 24,093 |
| $ | 2,302 | 9.6 | % | $ | 77,843 |
| $ | 71,996 |
| $ | 5,847 |
| 8.1 | % |
| |||
Percentage of revenue | 10.3 | % | 8.2 | % | 10.2 | % | 8.8 | % | ||||||||||||||||||
Our ability to remain competitive depends largely on continuously developing innovative technology, with new and enhanced features and systems and introducing them at competitive prices on a timely basis. Accordingly, based on our
25
strategic plan, we establish annual research and development budgets to fund programs that we expect will solve customers’ high value, high impact, ion implantation challenges.
Three months ended September 30, 2024 Compared with Three months ended September 30, 2023
Research and development expense was $26.4 million during the three months ended September 30, 2024, an increase of $2.3 million, or 9.6%, compared with $24.1 million during the three months ended September 30, 2023. The increase is primarily due to higher project and consulting expenses and higher personnel expenses associated with increases in wages partially offset by a decrease in variable compensation expense.
Nine months ended September 30, 2024 Compared with Nine months ended September 30, 2023
Research and development expense was $77.8 million during the nine months ended September 30, 2024, an increase of $5.8 million, or 8.1%, compared with $72.0 million during the nine months ended September 30, 2023. The increase is primarily due to higher project and consulting expenses and higher personnel expenses associated with increases in wages partially offset by a decrease in variable compensation expense and temporary employees.
Sales and Marketing
Three months ended | Period-to-Period | Nine months ended | Period-to-Period |
| ||||||||||||||||||||
September 30, | Change | September 30, | Change |
| ||||||||||||||||||||
2024 | 2023 | $ | % | 2024 | 2023 | $ | % |
| ||||||||||||||||
(dollars in thousands) | ||||||||||||||||||||||||
Sales and marketing |
| $ | 16,808 |
| $ | 16,465 |
| $ | 343 | 2.1 | % | $ | 51,483 |
| $ | 46,146 |
| $ | 5,337 |
| 11.6 | % |
| |
Percentage of revenue | 6.6 | % | 5.6 | % | 6.7 | % | 5.6 | % | ||||||||||||||||
Our sales and marketing expenses result primarily from the sale of our equipment and services through our direct sales force.
Three months ended September 30, 2024 Compared with Three months ended September 30, 2023
Sales and marketing expense was $16.8 million during the three months ended September 30, 2024, an increase of $0.3 million, or 2.1%, compared with $16.5 million during the three months ended September 30, 2023. The increase is primarily due to higher personnel expenses associated with increases in wages and stock compensation expense partially offset by a decrease in variable compensation expense.
Nine months ended September 30, 2024 Compared with Nine months ended September 30, 2023
Sales and marketing expense was $51.5 million during the nine months ended September 30, 2024, an increase of $5.3 million, or 11.6%, compared with $46.1 million during the nine months ended September 30, 2023. The increase is primarily due to higher personnel expenses associated with increases in wages and stock compensation expense partially offset by a decrease in variable compensation expense.
General and Administrative
Three months ended | Period-to-Period | Nine months ended | Period-to-Period |
| ||||||||||||||||||||
September 30, | Change | September 30, | Change |
| ||||||||||||||||||||
2024 | 2023 | $ | % | 2024 | 2023 | $ | % |
| ||||||||||||||||
(dollars in thousands) | ||||||||||||||||||||||||
General and administrative |
| $ | 19,854 |
| $ | 17,446 |
| $ | 2,408 |
| 13.8 | % | $ | 52,842 |
| $ | 48,519 |
| $ | 4,323 |
| 8.9 | % |
|
Percentage of revenue | 7.7 | % | 6.0 | % | 6.9 | % | 5.9 | % | ||||||||||||||||
Our general and administrative expenses result primarily from the costs associated with our executive, finance, information technology, legal and human resource functions.
26
Three months ended September 30, 2024 Compared with Three months ended September 30, 2023
General and administrative expense was $19.9 million during the three months ended September 30, 2024, an increase of $2.4 million, or 13.8%, compared with $17.4 million during the three months ended September 30, 2023. The increase is primarily due to an increase in bad debt expense of $2.8 million partially offset by lower personnel expenses associated with a decrease in variable compensation expense.
Nine months ended September 30, 2024 Compared with Nine months ended September 30, 2023
General and administrative expense was $52.8 million during the nine months ended September 30, 2024, an increase of $4.3 million, or 8.9%, compared with $48.5 million during the nine months ended September 30, 2023. The increase is primarily due to higher bad debt expense and higher personnel expenses associated with an increase in wages and stock compensation partially offset by a decrease in variable compensation expense.
Other Income (Expense)
Three months ended | Period-to-period |
| Nine months ended | Period-to-period |
| ||||||||||||||||||||
September 30, | change |
| September 30, | change |
| ||||||||||||||||||||
2024 | 2023 | $ | % |
| 2024 | 2023 | $ | % |
| ||||||||||||||||
(dollars in thousands) | |||||||||||||||||||||||||
Other income (expense): |
| $ | 8,452 |
| $ | 1,995 |
| $ | 6,457 |
| 323.7 | % |
| $ | 15,366 |
| $ | 4,449 |
| $ | 10,917 |
| 245.4 | % | |
Percentage of revenue |
| 3.4 | % |
| 0.7 | % |
| 2.1 | % |
| 0.6 | % | |||||||||||||
Other income (expense) consists of interest earned and accretion on our invested cash balances, interest expense relating to the finance lease obligation we incurred in connection with the 2015 sale of our headquarters facility and other financing obligations as well as foreign exchange gains and losses attributable to both fluctuations of the U.S. dollar against local currencies of the countries in which we operate and forward currency exchange contracts.
Other income was $8.5 million for the three months ended September 30, 2024, compared with other income of $2.0 million for the three months ended September 30, 2023. The $6.5 million increase in other income (expense) compared to the same prior year period was primarily due to an increase in interest income of $2.0 million and an increase in foreign exchange gains of $7.7 million, partially offset by foreign exchange losses of $3.2 million from forward currency exchange contracts. Other income was $15.4 million for the nine months ended September 30, 2024, compared with other income of $4.4 million for the nine months ended September 30, 2023. The $10.9 million increase in other income (expense) compared to the same prior year period was primarily due to an increase in interest income of $5.3 million, an increase in foreign exchange gains of $5.1 million and foreign exchange gains of $0.5 million from forward currency exchange contracts.
Income Tax Provision
Three months ended | Period-to-period |
| Nine months ended | Period-to-period |
| ||||||||||||||||||||||
September 30, | change |
| September 30, | change |
| ||||||||||||||||||||||
2024 | 2023 | $ | % |
| 2024 | 2023 | $ | % |
| ||||||||||||||||||
(dollars in thousands) | |||||||||||||||||||||||||||
Income tax provision |
| $ | 6,789 |
| $ | 7,744 |
| $ | (955) |
| (12.3) | % |
| $ | 20,593 |
| $ | 15,986 |
| $ | 4,607 |
| 28.8 | % | |||
Percentage of revenue |
| 2.6 | % |
| 2.6 | % |
| 2.7 | % |
| 1.9 | % | |||||||||||||||
Income tax expense was $6.8 million for the three months ended September 30, 2024, compared to $7.7 million for the three months ended September 30, 2023. The $0.9 million decrease was primarily due to a decrease in pre-tax income. Income tax expense was $20.6 million for the nine months ended September 30, 2024, compared to $16.0 million for the nine months ended September 30, 2023. The increase was primarily due to a decrease in the benefit received from share-based compensation.
27
The effective tax rate for the three and nine months ended September 30, 2024 was less than the U.S. statutory rate of 21% primarily attributable to the Foreign Derived Intangible Income deduction, Federal research and development tax credits and excess tax benefits from share-based compensation.
The deferred income taxes of $58.9 million and $53.4 million as of September 30, 2024 and December 31, 2023, respectively, reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, as well as the tax effect of carryforwards. As of September 30, 2024, we have recorded a $12.1 million valuation allowance in the U.S. against certain tax credits due to the uncertainty of their realization. Realization of our net deferred tax assets is dependent on future taxable income. We believe it is more likely than not that such assets will be realized; however, ultimate realization could be impacted by market conditions and other variables not known or anticipated at this time.
Liquidity and Capital Resources
At September 30, 2024, we had $120.1 million in unrestricted cash and cash equivalents and $459.3 million in short-term investments, in addition to $6.7 million in restricted cash. Management believes that maintaining a strong cash balance is necessary to fund a continuing ramp in our business which can require significant cash investment to meet sudden demand. Additionally, we are using cash to repurchase shares as part of our stock repurchase program and are considering both organic and inorganic opportunities to drive future growth, for which cash resources will be necessary.
Our liquidity is affected by many factors. Some of these relate specifically to the operations of our business, for example, the rate of sales of our products, and others relate to the uncertainties of global economic conditions, including the availability of credit and the condition of the overall semiconductor equipment industry. Our industry requires ongoing investments in operations and research and development that are not easily adjusted to reflect changes in revenue. As a result, profitability and cash flows can fluctuate more widely than revenue. Stock repurchases, as discussed below, also reduce our cash balances.
During the nine months ended September 30, 2024 and 2023, we generated $128.0 million and $91.3 million, respectively, of cash related to operating activities.
Investing activities for the nine months ended September 30, 2024 resulted in cash outflows of $117.8 million, $7.5 million of which was used for capital expenditures and $433.9 million of which was used to purchase short-term investments, offset by $323.6 million related to maturities of short-term investments. Investing activities for the nine months ended September 30, 2023 resulted in cash outflows of $74.2 million, $10.5 million of which was used for capital expenditures and $271.6 million of which was used to purchase short-term investments, offset by $207.9 million related to maturities of short-term investments.
Financing activities for the nine months ended September 30, 2024 resulted in a cash usage of $56.6 million. During the first nine months of 2024, (i) $45.4 million in cash was used to repurchase our common stock, (ii) $11.4 million was used for payments to government tax authorities for income tax withholding on employee compensation arising from the vesting of RSUs, where units are withheld by us to cover taxes, and (iii) $1.1 million was used to reduce the liability under the finance lease of our corporate headquarters. These amounts were partially offset by $1.2 million of proceeds related to the purchase of shares under our 2020 ESPP during the first nine months of 2024. In comparison, financing activities for the nine months ended September 30, 2023 resulted in cash usage of $53.2 million, of which (i) $37.5 million related to the repurchase of our common stock (ii) $15.8 million related to payments made to government tax authorities for income tax withholding on employee compensation arising from the vesting of RSUs, and (iii) $0.9 million relating to the reduction of our financing lease liability. These amounts were partially offset by $1.0 million of proceeds related to the purchase of shares under our 2020 ESPP and exercise of stock options during the first nine months of 2023.
As of September 30, 2024, we had a security deposit of $5.9 million related to the lease of our corporate headquarters in the form of a cash collateralized letter of credit issued with UBS Bank USA, which is classified as long-term restricted cash on our balance sheet.
We believe that based on our current market, revenue, expense and cash flow forecasts, our existing cash and cash equivalents will be sufficient to satisfy our anticipated cash requirements for the short- and long-term.
28
Commitments and Contingencies
Significant commitments and contingencies at September 30, 2024 are consistent with those discussed in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Note 16 to the consolidated financial statements included in our 2023 Form 10-K.
Item 3. Quantitative and Qualitative Disclosures about Market Risk.
As of September 30, 2024, there have been no material changes to the quantitative information about market risk disclosed in Item 7A, “Quantitative and Qualitative Disclosures about Market Risk” included in our 2023 Form 10-K.
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report (the “Evaluation Date”). Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of the Evaluation Date, these disclosure controls and procedures are effective.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during the three months ended September 30, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
29
PART II—OTHER INFORMATION
Item 1. Legal Proceedings.
We are, from time to time, a party to litigation that arises in the normal course of our business operations. We are not presently a party to any litigation that we believe might have a material adverse effect on our business operations.
Item 1A. Risk Factors.
As of September 30, 2024, there have been no material changes to the risk factors described in Item 1A, “Risk Factors” included in our 2023 Form 10-K.
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities.
In February 2022, our Board of Directors authorized a share repurchase program for up to $100 million of the Company’s common stock. This program was announced on March 1, 2022. In August 2023, our Board of Directors approved additional funding of $200 million for our stock repurchase program, to be available upon the full utilization of the $100 million repurchase funding approved in February 2022. This additional funding was announced on September 12, 2023. The Company’s share repurchase program does not have an expiration date.
The following table summarizes the stock repurchase activity, based upon settlement date, for the three months ended September 30, 2024 as well as the approximate dollar value of shares that may yet be purchased pursuant to our stock repurchase program:
| Total Number of Shares Purchased |
| Average Price Paid per Share |
| Total Number of Shares Purchased as Part of Publicly Announced Program |
| Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program | |||
(in thousands except per share amounts) | ||||||||||
July 1 through July 31 | 70 | $137.48 | 70 | 150,387 | ||||||
August 1 through August 31 | 48 | $111.33 | 48 | 145,011 | ||||||
September 1 through September 30 | — | $0.00 | — | 145,011 | ||||||
Total | 118 | 118 | ||||||||
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not Applicable.
Item 5. Other Information.
Lynnette C. Fallon, Executive Vice President, HR/Legal, General Counsel, and Secretary has announced her plan to retire in early 2025, at which time she will resign as an executive officer. The Company is engaged in a search for her successor. Following her retirement, Ms. Fallon will continue to serve as a senior advisor to the Company.
During the quarter ended
30
Item 6. Exhibits.
The following exhibits are filed herewith:
Exhibit |
| Description |
3.1 | ||
3.2 | ||
3.3 | ||
31.1* | ||
31.2* | ||
32.1** | ||
32.2** | ||
101* | The following materials from the Company’s Form 10-Q for the quarter ended September 30, 2024, formatted in inline eXtensible Business Reporting Language (iXBRL): (i) Consolidated Statements of Operations, (ii) Consolidated Statements of Comprehensive Income, (iii) Consolidated Balance Sheets, (iv) Consolidated Statements of Cash Flows and (v) Notes to Consolidated Financial Statements (Unaudited). Filed herewith. | |
104* | Cover Page Interactive Data File (formatted as iXBRL and contained in Exhibit 101). | |
* Filed herewith | ||
** This exhibit is being furnished rather than filed, and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K. | ||
31
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
AXCELIS TECHNOLOGIES, INC. | ||
DATED: November 7, 2024 | By: | /s/ JAMES G. COOGAN |
James G. Coogan | ||
Executive Vice President and Chief Financial Officer | ||
Duly Authorized Officer and Principal Financial Officer | ||
32